The Lancet, a nearly-century old medical journal, announced changes to its peer-review process because of a retraction in June of a large study involving the antimalarial hydroxychloroquine as a Covid-19 treatment after the article’s underlying data came under question.
The British journal said Thursday that the changes were intended to reduce the risk of misconduct in research. They include a new requirement that more than one author of a paper has direct access to raw data used in an article and can verify its authenticity,…
